PMCCPMCCPMCC

Search tips
Search criteria 

Advanced
Logo of bmcneusBioMed Centralsearchsubmit a manuscriptregisterthis journalBMC Neuroscience
 
Volume 9(Suppl 2);  2008
Reviews
Small molecule activators of the Trk receptors for neuroprotection
Nicholas JG Webster, Michael C Pirrung
BMC Neurosci. 2008; 9(Suppl 2): S1. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S1
PMCID:
PMC2604901
Abstract Full Text PDF–360K
Physiological and pathological aspects of Aβ in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators
Yael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, Orly Weinreb, Moussa BH Youdim
BMC Neurosci. 2008; 9(Suppl 2): S2. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S2
PMCID:
PMC2604902
Abstract Full Text PDF–500K
The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review
Juan Sanchez-Ramos, Shijie Song, Chuanhai Cao, Gary Arendash
BMC Neurosci. 2008; 9(Suppl 2): S3. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S3
PMCID:
PMC2604903
Abstract Full Text PDF–252K
Selective amyloid-β lowering agents
Michael S Wolfe
BMC Neurosci. 2008; 9(Suppl 2): S4. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S4
PMCID:
PMC2604888
Abstract Full Text PDF–227K
Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
Thomas Wisniewski, Martin Sadowski
BMC Neurosci. 2008; 9(Suppl 2): S5. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S5
PMCID:
PMC2604889
Abstract Full Text PDF–259K
Therapeutic potential of resveratrol in Alzheimer's disease
Valérie Vingtdeux, Ute Dreses-Werringloer, Haitian Zhao, Peter Davies, Philippe Marambaud
BMC Neurosci. 2008; 9(Suppl 2): S6. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S6
PMCID:
PMC2604890
Abstract Full Text PDF–272K
Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?
Wenjie Luo, Anna Rodina, Gabriela Chiosis
BMC Neurosci. 2008; 9(Suppl 2): S7. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S7
PMCID:
PMC2604891
Abstract Full Text PDF–523K
NADPH oxidase as a therapeutic target in Alzheimer's disease
Michelle L Block
BMC Neurosci. 2008; 9(Suppl 2): S8. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S8
PMCID:
PMC2604892
Abstract Full Text PDF–480K
Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein
Thomas Timm, Alexander Marx, Saravanan Panneerselvam, Eckhard Mandelkow, Eva-Maria Mandelkow
BMC Neurosci. 2008; 9(Suppl 2): S9. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S9
PMCID:
PMC2604893
Abstract Full Text PDF–1.4M
Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies
Jianhua Zhou, Qingming Yu, Tie Zou
BMC Neurosci. 2008; 9(Suppl 2): S10. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S10
PMCID:
PMC2604894
Abstract Full Text PDF–519K
Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential
Jun Ming Wang, Roberta Diaz Brinton
BMC Neurosci. 2008; 9(Suppl 2): S11. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S11
PMCID:
PMC2604895
Abstract Full Text PDF–1.7M
The p38α mitogen-activated protein kinase as a central nervous system drug discovery target
Aaron S Borders, Lucia de Almeida, Linda J Van Eldik, D Martin Watterson
BMC Neurosci. 2008; 9(Suppl 2): S12. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S12
PMCID:
PMC2604896
Abstract Full Text PDF–1.3M
Immune defects in Alzheimer's disease: new medications development
John R Cashman, Senait Ghirmai, Kenneth J Abel, Milan Fiala
BMC Neurosci. 2008; 9(Suppl 2): S13. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S13
PMCID:
PMC2604897
Abstract Full Text PDF–398K
Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase
Siew Yeen Chai, Holly R Yeatman, Michael W Parker, David B Ascher, Philip E Thompson, Hayley T Mulvey, Anthony L Albiston
BMC Neurosci. 2008; 9(Suppl 2): S14. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S14
PMCID:
PMC2604898
Abstract Full Text PDF–433K
Cognitive-enhancing effects of angiotensin IV
Paul R Gard
BMC Neurosci. 2008; 9(Suppl 2): S15. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S15
PMCID:
PMC2604899
Abstract Full Text PDF–266K
Hypometabolism as a therapeutic target in Alzheimer's disease
Lauren C Costantini, Linda J Barr, Janet L Vogel, Samuel T Henderson
BMC Neurosci. 2008; 9(Suppl 2): S16. Published online 2008 December 3. doi: 10.1186/1471-2202-9-S2-S16
PMCID:
PMC2604900
Abstract Full Text PDF–331K
Articles from BMC Neuroscience are provided here courtesy of
BioMed Central